Abstract 354: Influence of hemoglobin and uric acid level on Re admissions for Heart Failure
Introduction: Heart Failure admissions account for around 1%-2% of total healthcare expenditures (1).As seen in OPTIME-CHF study there was a prevalence of around 49% (of anemia) in heart failure patients and it was seen as an independent risk factor for the readmission and death (2). Along with this several studies have shown that elevated Uric acid is also associated with increase in readmissions and death. The aim of our study was to retrospectively analyze the readmission in relation to the uric acid and hemoglobin in the heart failure population at a teaching community hospital.
METHODS: Records of 258 patients with heart failure was studied retrospectively. Hemoglobin at discharge (greater then 10g/dl versus less than 10 g/dl)in relation to readmission within 1 month and between one to six months was studied . Along with this the relationship of uric acid level of less then 7.5 mg/dl versus greater than 7.5mg /dl in relation to readmission within 1 month was studied . Chi square test was used for statistical analysis.
RESULTS: 28.6% of patients with hemoglobin of <10 g/dl were readmitted within 1 month versus 20.60% of patients with the hemoglobin >10g/dl. For the re admissions between 1 and 6 months 21.4% of patients with hemoglobin less then 10 g/dl were readmitted versus 10.6% with the hemoglobin greater then 10g/dl. Similarly, it was seen that in patients with uric acid greater then 7.5 mg/dl 30% of the patients were readmitted in 1 month versus 23.3% with the uric acid of less then 7.5mg/dl.P value was not significant which was thought to be due to small sample size.
Conclusion: By optimizing the hemoglobin and uric acid levels rate of re admissions can be reduced .
References: World J Cardiol 2012 February 26; 4(2): 23-30
Author Disclosures: U. fatima: None. F. Ali: None. H. Prasad: None. D. Stapleton: None.
- © 2014 by American Heart Association, Inc.